Liposomal eribulin for advanced adenoid cystic carcinoma, gastric cancer, esophageal cancer, and small cell lung cancer.
Hibiki UdagawaShunji TakahashiMotohiro HiraoMakoto TaharaSatoru IwasaYasuyoshi SatoTakuya HamakawaKohei ShitaraHidehito HorinouchiKeisho ChinNorikazu MasudaTakuya SuzukiShiori OkumuraTakao TakaseReiko NagaiKan YonemoriPublished in: Cancer medicine (2022)
every 3 weeks was well tolerated for the treatment of several different tumor types, and larger studies in these populations are warranted.